Embolic Protection Devices Market Research Report 2019 By Key players & Growth Rate
The Embolic Protection Devices Market growth Factors such as the rising incidence of cardiovascular and neurovascular diseases, growing funding and investments, the launch of technologically advanced embolic protection devices, and rising demand for minimally invasive procedures are expected to drive the growth of the market.
The growth in this market is mainly attributed to factors such as the rising incidence of cardiovascular and neurovascular diseases, growing funding and investments.
Embolic Protection Device Market segmentation:
· based on type & material.
· based on the indication.
· based on application.
· based on end users.
· based on regions.
The Major Players Operating in the Embolic Protection Device Market:
The Global Embolic Protection Devices Market is consolidated in nature with very few players accounting for the major share of the market.
The prominent players in the Embolic Protection Devices Market are Boston Scientific (US), Medtronic (Ireland), Abbott (US), Cordis (A Cardinal Health Company) (US), Allium Medical (Israel), Contego Medical (US), W.L. Gore & Associates (US), Silk Road Medical (US), Claret Medical (US), and AngioSlide (Israel).
Medtronic dominated the global Embolic Protection Devices Market in 2017. The company offers a wide range of innovative products and therapies to treat more than 30 chronic diseases related to cardiac, diabetes and neurological and spinal conditions. To expand its existing product portfolio, the company focuses on inorganic growth strategies such as acquisitions. In January 2015, Medtronic acquired Covidien plc (Ireland), a manufacturer of cardiovascular products. This acquisition helped the company to expand its product portfolio as well as its market share.
Geographical Detailed Analysis for Embolic Protection Device Market:
North America dominated the Embolic Protection Devices Market.
The rising geriatric population and prevalence of cardiovascular and neurovascular diseases, increasing adoption of minimally invasive techniques, increasing availability of funding, and the presence of many medical device product manufacturers are driving the growth of the Embolic Protection Devices Market in North America.
However, the APAC is expected to grow at the highest CAGR during the forecast period. The high growth of this segment is attributed to the growing geriatric population, the rising prevalence of CVD, an increasing number of facilities, and rising healthcare expenditure.
We just sent you an email. Please click the link in the email to confirm your subscription!
OKSubscriptions powered by Strikingly